Share this page:

Crossover from IDE Trial CLN0009, Lung Volume Reduction Coil Treatment in Patients with Emphysema (RENEW) Study, IDE G110066

Phase: III
Status: Not Recruiting

Emphysema is a lung disease that limits the movement of air into and out of the lungs, making it harder to breathe. The investigational medical device is called the “RePneu® Coil System” (referred to as the Coil). The Coil is implanted in the airways in the lung, compressing the bullae (large air sacs) in the most diseased portion of the lung. This allows the diaphragm to work properly, and the remaining healthier portions of the lung to expand and function more efficiently. This study provides the Lung Volume Reduction Coil procedure to qualifying subjects who were enrolled as Control Subjects in and completed the Lung Volume Reduction Coil Treatment in Patients with Emphysema (RENEW) Study (NCT01608490).

Principal Investigator

Ganesh Krishna, MD, Palo Alto Medical Foundation


PneumRx, Inc.

NCT Number



John Tejeda, Enterprise Senior Director for Clinical Research
El Camino Hospital Clinical Research Department

For more information about this clinical trial, including trial status, eligibility and full trial listing, visit

You may also be interested in...

Visitor Screener

Visitor Restrictions

A visitor policy is in effect due to more restrictive measures being taken throughout the Bay Area.
HealthPerks Banner

Sign Up for HealthPerks

Get health information, event invitations, free screenings and more delivered to your inbox.
Find a doctor who will fit you well.

Find a Doctor

Use our directory to find a doctor with an office near our Mountain View or Los Gatos campus.